$LMRI

Lumexa Imaging Holdings, Inc. (LMRI): Submission of Matters to a Vote of Security Holders

Lumexa Imaging Holdings, Inc. (LMRI) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K false 0002071288 0002071288 2026-06-10 2026-06-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 10,

Original reporting
Published Jun 12, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 12, 2026, 8:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$LMRI
Neutral
high confidence
Mentioned
$LMRI
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$LMRINeutralLow
01

Why it matters

The company confirms (1) election of three Class I directors and (2) ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2026.

02

Market read

Primarily confirms governance/audit continuity; no new financial or strategic catalyst is disclosed.

03

What to watch

Traders may still watch for follow-on disclosures (e.g., subsequent 8-Ks for director/officer appointments or committee changes), but none are included here.

Relevance 6/10Novelty 2/10Timing: Filed June 12, 2026 (covering June 10 annual meeting vote results)

Background

This is an SEC 8-K Item 5.07 reporting the final voting results from Lumexa Imaging Holdings’ June 10, 2026 annual meeting.

Company-level read

Ticker impact

$LMRINeutralHigh confidence
Context

Lumexa Imaging Holdings held its 2026 annual meeting and stockholders elected three Class I directors and ratified PwC as auditor for 2026.

Expected impact

Likely minimal near-term impact; any reaction would be sentiment/positioning rather than fundamentals.

Evidence & confidence

The filing reports voting results only; it does not include new guidance, financial statements, transactions, or regulatory findings.

Market effects

No sector read-across; auditor ratification and director elections are standard for public companies.

None indicated.

None indicated.

Counterpoint

If the market had been speculating about auditor/board changes, this could reduce uncertainty, but the filing provides no evidence of controversy or change in strategy.

Key entities

  • Lumexa Imaging Holdings, Inc.

    Nasdaq-listed company reporting annual meeting voting results on SEC Form 8-K.

  • PricewaterhouseCoopers LLP

    Ratified independent registered public accounting firm for 2026.

Related articles

$LMRIHighAI 8/10

Lumexa Imaging (LMRI) Q2 2026 Earnings Call Transcript

Lumexa Imaging (LMRI) reported Q2 2026 revenue of $264.2M, up 5.1% YoY, with adjusted EBITDA of $56.4M. Net income turned positive at $2.7M, reversing a prior-year loss. Advanced imaging volume grew 6.8%, driving revenue increases. The company narrowed EBITDA guidance to $235M-$241M and highlighted expansion plans, including new PET machines and FastScan technology.

$LMRIMed

Lumexa Imaging Holdings, Inc. (LMRI): Results of Operations and Financial Condition

Lumexa Imaging Holdings, Inc. (LMRI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Lumexa Imaging Announces Second Quarter 2026 Results RALEIGH, N. C., August 12, 2026—Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, today reported results for the second quarter ended June 30, 2026, and updated it

$LMRIMed

Lumexa Imaging Announces Joint Venture with Hospital for Special Surgery (HSS) to Expand Advanced Outpatient Imaging in New York

Lumexa Imaging (NASDAQ: LMRI) said it formed a strategic joint venture with Hospital for Special Surgery (HSS) to expand advanced outpatient imaging across the New York City metro area. The deal is Lumexa’s ninth joint venture and supports its growth strategy via de novo development, acquisitions, and partnerships. Lumexa reported about 4 million outpatient procedures system-wide in 2025.

$HDBMed

HDFC Bank CEO Jagdishan to step down in October as governance pressures mount

HDFC Bank, India's largest private lender, announced CEO Sashidhar Jagdishan will step down in October, not seeking reappointment. This follows governance concerns, regulatory scrutiny, and a 27% stock decline since January. The bank's board previously penalized Jagdishan for business overreach. Investors have also been disappointed by lack of financial gains from the 2023 merger with HDFC Ltd.

$WDSMed

Woodside Drops Its Climate Target and Leans Harder on Senegal

Woodside Energy abandoned its long-term Scope 3 climate targets, including a US$5 billion clean-energy investment plan. The company reported a 7% rise in underlying net profit to US$1.33 billion and a 27% increase in statutory net profit to US$1.67 billion. Woodside's Senegalese field, Sangomar, is central to its strategy, with production averaging 99,000 barrels per day. The company is also in a tax arbitration with Senegal's government over a US$68 million reassessment.